Video

How Do We Quantify Continuous Manufacturing Benefits?

Source: Sartorius

In this segment of the Bioprocess Online Live event Biopharma PAT: Gateway To Continuous Manufacturing, Paul Testa, EVP of Supply Chain and Operations at Kyowa Kirin North America and Barrett Fallentine, Director, Process & Product Development at Pharmatech Associates cover the intended, expected, and actual outcomes of continuous manufacturing initiatives in biopharma. They also tackle audience questions on modality-specific benefits of continuous manufacturing, and how much those benefits cross over from one product to the next.

View the full presentation on-demand here.

 

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

Sartorius